405: A Multicenter Prospective, Randomized, Placebo-Controlled Trial of a CXCL8 Inhibitor (Reparixin) To Prevent Primary Graft Dysfunction after Lung Transplantation Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Meyers, BF
  • Keshavjee, Shafique
  • Zamora, MR
  • Davis, RD
  • Smith, MA
  • McFadden, PM
  • Hertz, MI
  • Daffonchio, L
  • Novellini, R

publication date

  • February 2008